Friday, July 31, 2026

Wontech to host ‘Wave Tokyo’ in Japan, officially launch SANDRO Dual

Wontech will host "Wave Tokyo" on April 26 to launch SANDRO Dual, expanding its presence in Asia after "Wave Beijing."

Neurophet AQUA AD Plus: Revolutionizing Alzheimer’s Diagnosis with AI at AD/PD 2026

Neurophet showcased its AI solutions for Alzheimer's at AD/PD 2026, aiming to foster collaborations in treatment development.

Are Korean Universities Ready for the Surge in Medical Students?

Seoul's medical schools face faculty shortages and infrastructure issues amid expanded enrollment, raising concerns about education quality.

Sang Hyuk Seo

Discover How MobiCARE’s Wearable ECG Solution Detects Atrial Tachycardia Early

Daewoong Pharmaceutical's mobiCARE device detects atrial tachycardia early, enhancing cardiac health screenings for better patient outcomes.

How GCCL and KBIOHealth’s New Agreement Will Transform Clinical Trials in South Korea

GCCL signs MOU with KBIOHealth to enhance clinical research and drug development, integrating public research with industry expertise.

How AI-Powered Wearable Tech is Revolutionizing Epilepsy Monitoring in 2026

SK Biopharmaceuticals and Emory University launch a two-year AI project for seizure detection using EEG data and wearable devices.

Phonak Holds Leadership Seminar, Unveils New Virto Infinio R hearing aid

Phonak's seminar showcased AI hearing tech and the new Virto Infinio R hearing aid, emphasizing hearing health in an aging society.

New Fat Reduction Injection Shows 73.7% Success in Phase 3 Trial

AMIPHARM reveals promising phase 3 results for AYP-101, a fat reduction injection, at IMCAS 2026, targeting submental fat safely.

New Diabetes Treatment: Chong Kun Dang’s Dubiempol Sustained Release Tablet Approved for Type 2 Diabetes in Korea

Chong Kun Dang's type 2 diabetes treatment, Dubiempol, gains approval, offering a new option for patients with uncontrolled blood sugar.

Unlocking the Future of Healthcare: How Dong-A ST and Dou are Revolutionizing AI Solutions in 2026

Dong-A ST partners with Dou for AI solutions to enhance digital healthcare and improve patient experiences in hospitals nationwide.

SleepQ vs. Traditional Medications: Which is the Future of Insomnia Treatment?

Welt aims to complete clinical trials for its SleepQ insomnia device by year-end, targeting listing on Germany's DiGA reimbursement system.

Novosis Trauma: The Game-Changing Bone Substitute Approved in Malaysia

CG MedTech's Novosis Trauma, a bone substitute for fractures, gains approval in Malaysia, marking its first international registration.

Discover the Breakthrough: Daewoong’s CleanCol Tablet Reduces Dosage for Effective Colon Cleansing

Daewoong Pharmaceutical's Cleancol Tab. shows effective bowel cleansing with fewer tablets, improving patient adherence during colonoscopy prep.

Discover the Legacy: Hanmi Group Unveils Monument Honoring Founder Lim Seong-ki

Hanmi Group honors founder Lim Seong-ki with a bronze sculpture, celebrating his legacy in pharmaceutical innovation and drug development.

What Makes DOOTH the Game-Changer in Absorbable Sutures? Discover Its Unique Advantages!

CGBio is expanding its aesthetic business by exporting the absorbable suture DOOTH to Japan, aiming for global recognition and regulatory approvals.

Hemlibra Breakthrough: 91% of Hemophilia Patients in Japan Experience No Adverse Reactions!

JW Pharmaceutical's Hemlibra shows 91% safety in Japanese hemophilia patients, with no adverse reactions in long-term study.

Can AI Speed Up Drug R&D?: PharmGen Science Teams With Polaris AI Pharma Across the Full Development Cycle

PharmGen Science partners with Polaris AI Pharma to enhance drug development using AI technologies and optimize R&D processes.

Top News

- Our Sponsors Ad -

Follow us